Highlighting recent achievements to advance more effective cancer immunotherapy
From 17 to 19th October 2024, the XXI Italian Network for Bio-Immunotherapy of Tumors Meeting (NIBIT) took place in Palermo, in the marvelous historical location of Teatro Politeama, under the auspices of the Italian Association of Medical Oncology (AIOM), Italian Association of Cancer Research (AIRC), Fondazione Pezcoller, Italian Alliance against Cancer (ACC), Italian Lymphoma Foundation (FIL), Grazia Focacci Foundation and Melagioco Foundation. The conference covered a spectrum of topics ranging from target discovery to therapeutic advances in immuno-oncology, bringing world-renowned experts to present groundbreaking innovations in basic, translational, and clinical cancer research. Six sessions focused on cellular therapies, digital pathology, vaccines, tertiary lymphoid structures, and microenvironment in order to get deep insights on how to personalize diagnosis and therapies in the clinical setting. Young investigators had the opportunity to meet and greet their mentors, promoting the synergy of the academic and industrial sectors within the national and international panorama, discussing the application of artificial intelligence on multi-specific antibodies, drug conjugates, and antibody fusion proteins that are advancing the efficacy of precision medicine and minimizing off-target effects.
Authors
- Paola Nisticò (ORCID: https://orcid.org/0000-0003-4409-2261)
- Antonio Sica (ORCID: https://orcid.org/0000-0002-8342-7442)
- Anna Mondino (ORCID: https://orcid.org/0000-0003-0833-6927)
- Pier Francesco Ferrucci (ORCID: https://orcid.org/0000-0001-6255-5851)
- Matteo Benelli (ORCID: https://orcid.org/0000-0003-1227-356X)
- Sheila Spada (ORCID: https://orcid.org/0000-0001-8644-2237)
- Lorenzo D’Ambrosio (ORCID: https://orcid.org/0000-0003-3294-8819)
- Vincenzo Bronte (ORCID: https://orcid.org/0000-0002-3741-5141)
- Marcella Tazzari (ORCID: https://orcid.org/0000-0002-8112-1773)
- Giulia Casorati (ORCID: https://orcid.org/0000-0002-5102-4112)
- Roberta Sommaggio (ORCID: https://orcid.org/0000-0002-5682-5867)
- Paola Allavena (ORCID: https://orcid.org/0000-0002-6697-6028)
- Beatrice Belmonte (ORCID: https://orcid.org/0000-0001-9668-0925)
- Claudio Tripodo (ORCID: https://orcid.org/0000-0002-0821-6231)
- Roberto Ferrara (ORCID: https://orcid.org/0000-0001-6443-5642)
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Padua (IT)
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- MultiMedica (IT)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Istituto Oncologico Veneto (IT)
- IFOM (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Hospital of Prato (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Turin (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Journal of Experimental & Clinical Cancer Research
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1186/s13046-025-03316-8
- Citations
- 3
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Associazione Italiana di Oncologia Medica
- Associazione Italiana per la Ricerca sul Cancro
- Fondazione Pezcoller
- Alleanza Contro il Cancro